This content is machine translated Heart failure in the light of the latest evidence MRAs offer advantages across the entire EF spectrum At the swissESCupdate, cardiology experts summarized important content from this year’s Annual Meeting of the European Society of Cardiology . In the area of heart failure, studies on the use…
View Post 8 min This content is machine translated Heart failure: ESC guideline update 2023 Therapy-relevant new evidence on the entire EF spectrum The update of the ESC guideline on the treatment of heart failure includedthe results of large randomized studies that were not published until after the guideline was published in 2021.…
View Post 5 min This content is machine translated Heart failure in type 2 diabetes Success story of SGLT-2 inhibitors – impressive evidence base. The SGLT(“sodium glucose-linked transporter”)-2 inhibitors have demonstrated cardioprotective effects in addition to antidiabetic effects. The current evidence supports the benefit of several agents of SGLT-2-i in the treatment of heart…
View Post 5 min This content is machine translated Heart failure Pharmacotherapy in HFrEF and HFmrEF – Combination of four as gold standard. Important therapeutic goals in chronic heart failure are to improve quality of life and to reduce the risk of hospitalization and mortality. According to current evidence, guideline-based therapy with the…
View Post 6 min This content is machine translated Heart failure Dapagliflozin now approved in preserved ejection fraction [1,4]** After dapagliflozin had been approved for some time for heart failure with reduced ejection fraction, Swissmedic now granted an indication extension for heart failure with mildly reduced or preserved ejection…
View Post 8 min This content is machine translated Heart failure Ejection fraction as a therapy criterion Heart failure with reduced ejection fraction (HFrEF) is characterized by a left ventricular ejection fraction (LVEF) in the range ≤40% according to the current classification, whereas heart failure with preserved…
View Post 6 min This content is machine translated Suspected heart failure - what to do? Expert recommendations up-to-date According to the European Society of Cardiology (ESC) guideline updated last year, heart failure is classified into HFrEF, HFmrEF, and HFpEF according to left ventricular ejection fraction. Regarding drug therapy, early…
View Post 3 min This content is machine translated Heart failure HFrEF – the four pillars of modern pharmacotherapy Chronic heart failure is one of the leading causes of death and reasons for hospitalization in developed countries. The prognosis is often poor – within five years, about half of…
View Post 12 min This content is machine translated Heart failure Physical training in patients with HFrEF and HFpEF. The increasing prevalence of heart failure is a major medical and economic problem. The number of patients hospitalized for heart failure has been increasing for years. The clinical picture of… CME-Test
View Post 12 min This content is machine translated Heart failure Physical training in patients with HFrEF and HFpEF. The increasing prevalence of heart failure is a major medical and economic problem. The number of patients hospitalized for heart failure has been increasing for years. The clinical picture of…
View Post 7 min This content is machine translated Chronic heart failure MitraClips: What do studies say? The use of percutaneous mitral valve repair using a MitraClip device for the treatment of (moderately) severe functional mitral regurgitation is controversial. Previous studies were either terminated due to insufficient…
